Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392078 · ClinicalTrials.gov registry record
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
A clinical trial, sponsored by Monteris Medical.
- Completed
- Registry status
- 1,153
- Enrollment target
NCT02392078 is a clinical trial that has completed, run by Monteris Medical. The registered enrollment target is 1,153 participants.
The verdict
NCT02392078 has completed, sponsored by Monteris Medical.
- COMPLETED
- Registry status
- 1,153 participants
- Enrollment target
Study Summary
The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.
Interventions
- DEVICE NeuroBlate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,153 participants |
| Start Date | 2015-10 |
| Est. Completion | 2023-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02392078
The ClinicalTrials.gov registry entry for NCT02392078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monteris Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroBlate System is the first listed.
NCT02392078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02392078 about?
NCT02392078 is a clinical study titled "Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System". The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a p...
What is the current status of trial NCT02392078?
This trial is currently completed. The enrollment target is 1,153 participants. The study started on 2015-10. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT02392078?
The interventions under investigation include: NeuroBlate System (DEVICE).
Who is sponsoring clinical trial NCT02392078?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.